
Jane J. Zara
Examiner (ID: 18595)
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1674, 1637, 1635 |
| Total Applications | 1842 |
| Issued Applications | 1032 |
| Pending Applications | 285 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5609078
[patent_doc_number] => 20060270594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Methods and compositions for modulating hyperstabilized c-met'
[patent_app_type] => utility
[patent_app_number] => 11/388757
[patent_app_country] => US
[patent_app_date] => 2006-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 32424
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270594.pdf
[firstpage_image] =>[orig_patent_app_number] => 11388757
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/388757 | Methods and compositions for modulating hyperstabilized c-met | Mar 23, 2006 | Issued |
Array
(
[id] => 5700655
[patent_doc_number] => 20060217340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Methods and products for treating hypertension by modulation of TRPC3 channel activity'
[patent_app_type] => utility
[patent_app_number] => 11/388194
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19608
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217340.pdf
[firstpage_image] =>[orig_patent_app_number] => 11388194
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/388194 | Methods and products for treating hypertension by modulation of TRPC3 channel activity | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5874171
[patent_doc_number] => 20060166255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Methods of using 48149, a human Aminopeptidase family member'
[patent_app_type] => utility
[patent_app_number] => 11/387011
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 50380
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166255.pdf
[firstpage_image] =>[orig_patent_app_number] => 11387011
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/387011 | Methods of using 48149, a human Aminopeptidase family member | Mar 21, 2006 | Abandoned |
Array
(
[id] => 5521952
[patent_doc_number] => 20090029933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'INHIBITOR OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA COACTIVATOR 1'
[patent_app_type] => utility
[patent_app_number] => 11/909323
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4788
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 70
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029933.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909323
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909323 | INHIBITOR OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA COACTIVATOR 1 | Mar 19, 2006 | Abandoned |
Array
(
[id] => 5596846
[patent_doc_number] => 20060160764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'LIMKs as modifiers of p53 pathway and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/378923
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14458
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160764.pdf
[firstpage_image] =>[orig_patent_app_number] => 11378923
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/378923 | LIMKs as modifiers of p53 pathway and methods of use | Mar 16, 2006 | Abandoned |
Array
(
[id] => 5677791
[patent_doc_number] => 20060183147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Methods of identifying genes which modulate myelination'
[patent_app_type] => utility
[patent_app_number] => 11/352907
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 16881
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183147.pdf
[firstpage_image] =>[orig_patent_app_number] => 11352907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352907 | Methods of identifying genes which modulate myelination | Feb 12, 2006 | Abandoned |
Array
(
[id] => 4765600
[patent_doc_number] => 20080176812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Allele-specific silencing of disease genes'
[patent_app_type] => utility
[patent_app_number] => 11/343366
[patent_app_country] => US
[patent_app_date] => 2006-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 32652
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176812.pdf
[firstpage_image] =>[orig_patent_app_number] => 11343366
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/343366 | Allele-specific silencing of disease genes | Jan 30, 2006 | Abandoned |
Array
(
[id] => 5620026
[patent_doc_number] => 20060189560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Molecular method to augment RNA mediated gene silencing'
[patent_app_type] => utility
[patent_app_number] => 11/340561
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4618
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189560.pdf
[firstpage_image] =>[orig_patent_app_number] => 11340561
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/340561 | Molecular method to augment RNA mediated gene silencing | Jan 26, 2006 | Abandoned |
Array
(
[id] => 243339
[patent_doc_number] => 07589073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/332729
[patent_app_country] => US
[patent_app_date] => 2006-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 35
[patent_no_of_words] => 50919
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589073.pdf
[firstpage_image] =>[orig_patent_app_number] => 11332729
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/332729 | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics | Jan 11, 2006 | Issued |
Array
(
[id] => 250719
[patent_doc_number] => 07582475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-01
[patent_title] => 'Vectors and methods for high throughput co-expression'
[patent_app_type] => utility
[patent_app_number] => 11/327200
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 129
[patent_figures_cnt] => 131
[patent_no_of_words] => 19626
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/582/07582475.pdf
[firstpage_image] =>[orig_patent_app_number] => 11327200
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/327200 | Vectors and methods for high throughput co-expression | Jan 5, 2006 | Issued |
Array
(
[id] => 5349971
[patent_doc_number] => 20090005332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Compositions and Methods for Modulating Gene Expression Using Self-Protected Oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/813190
[patent_app_country] => US
[patent_app_date] => 2005-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9871
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20090005332.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813190 | Compositions and Methods for Modulating Gene Expression Using Self-Protected Oligonucleotides | Dec 29, 2005 | Abandoned |
Array
(
[id] => 5865053
[patent_doc_number] => 20060099183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft'
[patent_app_type] => utility
[patent_app_number] => 11/300722
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9688
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11300722
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/300722 | Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5785462
[patent_doc_number] => 20060205078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Induction of RNA Interference by Aberrant RNA'
[patent_app_type] => utility
[patent_app_number] => 11/306044
[patent_app_country] => US
[patent_app_date] => 2005-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3953
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205078.pdf
[firstpage_image] =>[orig_patent_app_number] => 11306044
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/306044 | Induction of RNA Interference by Aberrant RNA | Dec 13, 2005 | Abandoned |
Array
(
[id] => 4682242
[patent_doc_number] => 20080248468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Method for Improved Selection of Rnai Transfectants'
[patent_app_type] => utility
[patent_app_number] => 11/792902
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5829
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248468.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792902
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792902 | Method for Improved Selection of Rnai Transfectants | Dec 12, 2005 | Abandoned |
Array
(
[id] => 9127377
[patent_doc_number] => 08575327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-05
[patent_title] => 'Conserved HBV and HCV sequences useful for gene silencing'
[patent_app_type] => utility
[patent_app_number] => 13/065601
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 15
[patent_no_of_words] => 38260
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13065601
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/065601 | Conserved HBV and HCV sequences useful for gene silencing | Dec 11, 2005 | Issued |
Array
(
[id] => 7518916
[patent_doc_number] => 07973017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => 'Treatment of cancer by inhibition of IGFBP\'s and clusterin'
[patent_app_type] => utility
[patent_app_number] => 11/287334
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 6241
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/973/07973017.pdf
[firstpage_image] =>[orig_patent_app_number] => 11287334
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/287334 | Treatment of cancer by inhibition of IGFBP's and clusterin | Nov 22, 2005 | Issued |
Array
(
[id] => 5662125
[patent_doc_number] => 20060252721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Potent LNA oligonucleotides for the inhibition of HIF-1a expression'
[patent_app_type] => utility
[patent_app_number] => 11/271686
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 22838
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252721.pdf
[firstpage_image] =>[orig_patent_app_number] => 11271686
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/271686 | Potent LNA oligonucleotides for the inhibition of HIF-1A expression | Nov 8, 2005 | Issued |
Array
(
[id] => 9401729
[patent_doc_number] => 08691781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-08
[patent_title] => 'Compositions for treating respiratory viral infections and their use'
[patent_app_type] => utility
[patent_app_number] => 11/792179
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16362
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11792179
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792179 | Compositions for treating respiratory viral infections and their use | Nov 3, 2005 | Issued |
Array
(
[id] => 34046
[patent_doc_number] => 07786291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Compositions and methods for short interfering nucleic acid inhibition of Nav1.8'
[patent_app_type] => utility
[patent_app_number] => 11/259588
[patent_app_country] => US
[patent_app_date] => 2005-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15763
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/786/07786291.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259588
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259588 | Compositions and methods for short interfering nucleic acid inhibition of Nav1.8 | Oct 25, 2005 | Issued |
Array
(
[id] => 5785221
[patent_doc_number] => 20060204977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Cross reactive arrays of three-way junction sensors for steroid determination'
[patent_app_type] => utility
[patent_app_number] => 11/251496
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 95
[patent_no_of_words] => 26713
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204977.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251496
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251496 | Cross reactive arrays of three-way junction sensors for steroid determination | Oct 13, 2005 | Issued |